Formulation and transdermal delivery of aciclovir and ketoconazole for HIV/AIDS patients
Date
2010Author
Jacobs, G.A.
Gerber, M.
Malan, M.M.
Du Preez, J.
Du Plessis, J.
Metadata
Show full item recordAbstract
Due to their compromised immune systems, HIV/ AIDS-
infected individuals are more susceptible to skin infections.
Since fungal and viral cutaneous manifestations are
frequently encountered in combination in HIV/AIDS
patients, it is appropriate to formulate a topical product
containing both ketoconazole (antifungal) and aciclovir
(antiviral)
URI
http://hdl.handle.net/10394/16030https://onlinelibrary.wiley.com/doi/abs/10.1211/jpp.62.06.0016
https://doi.org/10.1211/jpp.62.06.0016
Collections
- Faculty of Health Sciences [2377]